TRAF6 and non-small cell lung carcinoma: Feng et al. [52] demonstrated that the aberrant overexpression of the TRAF6 in lung cancer tissues triggered activation of AKT thus, boosting cancer proliferation and progression in non-Small Cell Lung Cancer (NSCLC).